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Abstract
Background: The General Practice Research Database (GPRD) and Doctor's Independent
Network Database (DIN), are large electronic primary care databases compiled in the UK during
the 1990s. They provide a valuable resource for epidemiological and health services research.
GPRD (based on VAMP) presents notes as a series of discrete episodes, whereas DIN is based on
a system (MEDITEL) that used a Problem Orientated Medical Record (POMR) which links
prescriptions to diagnostic problems. We have examined the implications for research of these
different underlying philosophies.
Methods: Records of 40,183 children from 141 practices in DIN and 76,310 from 464 practices
in GRPD who were followed to age 5 were used to compare the volume of recording of prescribing
and diagnostic codes in the two databases. To assess the importance and additional value of the
POMR within DIN, the appropriateness of diagnostic linking to skin emollient prescriptions was
investigated.
Results: Variation between practices for both the number of days on which prescriptions were
issued and diagnoses were recorded was marked in both databases. Mean number of "prescription
days" during the first 5 years of life was similar in DIN (19.5) and in GPRD (19.8), but the average
number of "diagnostic days" was lower in DIN (15.8) than in GPRD (22.9). Adjustment for linkage
increased the average "diagnostic days" to 23.1 in DIN. 32.7% of emollient prescriptions in GPRD
appeared with an eczema diagnosis on the same day compared to only 19.4% in DIN; however,
86.4% of prescriptions in DIN were linked to an earlier eczema diagnosis. More specifically 83% of
emollient prescriptions appeared under a problem heading of eczema in the 121 practices that
were using problem headings satisfactorily.
Conclusion: Prescribing records in DIN and GPRD are very similar, but the usage of diagnostic
codes is more parsimonious in DIN because of its POMR structure. Period prevalence rates will
be underestimated in DIN unless this structure is taken into account. The advantage of the POMR
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is that in 121 of 141 practices using problem headings as intended, most prescriptions can be linked
to a problem heading providing a specific reason for their issue.
Background
Primary care computing in the United Kingdom has a
longer history than in any other country[1]. The design of
the early general practice software systems (many of
which continue in use in developed forms) grew out of
the personal preferences for particular styles of medical
record of the general practitioners who designed and used
the systems. Of the two systems developed in the mid
1980s, Meditel System 5 software was heavily influenced
by the concept of the Problem Orientated Medical Record
(POMR)[2]. It was designed to present the medical record
as a chain of intertwined but discrete problems, with pre-
scriptions being linked to diagnoses under problem head-
ings. In contrast VAMP Medical software presented the
notes as a series of discrete episodes, essentially uncon-
nected, an approach taken by a number of other software
suppliers.
An early business model on the part of the two software
suppliers (VAMP Health, now IPS, and Meditel, now
Torex) envisaged the provision of free or subsidised com-
puter hardware to general practitioners in exchange for
their contribution of coded diagnostic and prescribing
data to the supplier's database. Neither supplier now has
any connection with the databases they created (the Gen-
eral Practice Research Database (GPRD) (VAMP) and the
Doctors' Independent Network Database (DIN) (Medi-
tel)), but both databases continue to collect data. These
large scale databases built up during the 1990's provide a
valuable resource for epidemiological and health services
research. However, the implications for research of the
different philosophies underlying the databases as well as
their different system for coding diagnoses and prescrib-
ing (Oxford Medical Information System [OXMIS] and
subsequently 5-Byte Read codes in GPRD, and 4-Byte
Read codes in DIN) have been little studied. To do so is
important for two reasons: first, to make best use of the
large volumes of data collected during the 1990's; second,
to inform the development of the electronic patient
record, which thus far appears to have proceeded without
formal comparisons of the different databases built up.
The problem orientation of DIN with linkage of prescrip-
tions to problems enables, in principle, reasons for all pre-
scriptions to be clearly identified. The absence of such
linkage in GPRD means that contributors of data to the
database are expected to code a specific reason for each
prescription issued. While in theory this occurs for acute
prescriptions, allowing linkage by date, only the original
indication for repeated treatment is required to be
entered[3].
In this study we assess the importance of these differences
by analysing birth cohorts in DIN and GPRD to: (i) com-
pare the volume of recording of prescribing and diagnos-
tic codes in DIN and GPRD (both overall and by
examining variation between practices); (ii) examine the
value of linkage for identifying explicitly the reason for
prescribing. The latter is achieved by focussing on reasons
for prescriptions of skin emollients.
Methods
Background to DIN and GPRD
We identified 142 UK general practices from the DIN
database that were considered good quality data provid-
ers, based on a series of indicators which we have previ-
ously described[4]. Here we use data recorded between
January 1989 and February 2002 – one practice is
excluded from this paper because it did not contribute for
a full 5-year period. The main data considered here consist
of the amalgamation of two files – "Notes" and "Issues".
The "Notes" file covers diagnoses, symptoms, administra-
tion, medical history, vaccinations and prescriptions
other than repeats. The "Issues" file contains more
detailed prescribing data on all prescriptions including
repeats. DIN practices used Read Codes for recording both
drugs and diagnoses.
An example of a record from DIN, ordered by event date,
and including entries from both the "Notes" and "Issues"
file for one child is given in Table 1. A diagnosis of eczema
is made on 9/2/96 and a prescription for hydrocortisone
cream issued. In this instance the diagnosis of eczema is
the problem heading and is assigned Problem Number 5.
On 2/4/96 and 24/6/96 emollient prescriptions are
recorded under the same problem heading. Notice that
more than one diagnosis can be placed under this heading
if necessary. Thus if the child developed nappy rash later,
the GP could choose to add this under the existing prob-
lem heading. The alternative would be to start a new
heading.
The GPRD is well established in epidemiological
research[5]. Here we consider data collected from 464
practices between 1989 and 1998 only. For much of this
period, practices in GPRD used the OXMIS coding system,
but since 1997 some practices have used Read Codes
(Unified 5-Byte Version 2 Set) for diagnoses. PPA codes
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were used for recording drugs, which were mapped to BNF
chapters using a browser.
In preliminary work we compared all patients fully regis-
tered in DIN in 1998 (approximately 1 million subjects),
to that of GPRD in the same year (based on Key Health
Statistics[6]). We found the age-sex population structure
of the two databases to be highly comparable to each
other and National Statistics population estimates. How-
ever there were differences in geography, with DIN having
60.3% of its population in the South, compared to only
41.7% for GPRD, neither of which compare closely to the
population estimate of 49.8%. It was important to adjust
for this difference when we compared the prevalence of
ischaemic heart disease that is known to vary by region[4].
Defining birth cohorts in each database
We created a subset of each database that included only
children who were "born into" the database, which we
defined as those fully registered within 3 months of their
date of birth[7]. In this report we further restrict to chil-
dren who were continually registered up to age 5. Using
birth cohorts in the analyses have a number of advan-
tages: (i) all consultations should be recorded in 'real-
time' and there would be no reliance on retrospective
data; (ii) comparisons within and between databases
Table 1: Example record from DIN illustrating linkage by problem number (Selected variables from the combined "Notes" and "Issues" 
files are ordered by event date. Type C indicates a chapter heading)
Event Seq Probno Type Dosea Dosei Repeat ReadRC ReadRu
25/12/95 8 4 C 63.. Birth details
25/12/95 10 4 N K4B1 Normal delivery – occipitoant.
25/12/95 12 4 P 6363 Baby BW = 10%-24% (2850–3149 g)
25/12/95 14 4 P 62P1 Breast fed
08/01/96 2 1 C 65.. Infectious dis:prevent/control
08/01/96 4 2 C 9192 Registered child surveillance
08/01/96 6 3 C 133D Child of
10/01/96 16 225 A 9123 Patient reg. form sent to FPC
10/01/96 18 225 A 919Z Child surveillance admin.NOS
09/02/96 20 5 C L2.. Dermatitis/eczemas
09/02/96 21 5 M 15 a2 A m411 HYDROCORTISONE 1% cream 15 g
09/02/96 22 2 P 64D4 Child 6 week exam. normal
26/02/96 24 1 P 65I1 First DTP (triple)+polio vacc.
26/02/96 26 1 P 657A 1st haemophilus B vaccination
25/03/96 28 1 P 65I2 Second DTP (triple)+polio vacc
25/03/96 30 1 P 657B 2nd haemophilus B vaccination
02/04/96 37 5 M 100 Up A m271 OILATUM PLUS bath emollient
22/04/96 38 1 P 65I3 Third DTP (triple)+polio vacc.
22/04/96 40 1 P 657C 3rd haemophilus B vaccination
24/06/96 43 5 M 400 __ A m23k SUDOCREM cream 400 g
24/06/96 45 5 M 500 Ap A m111 AQUEOUS cream
24/06/96 47 5 M 100 Up R m271 OILATUM PLUS bath emollient
23/08/96 48 2 P 64E4 8–9 month exam normal
30/08/96 50 2 P 64M5 Child exam.: hearing
24/02/97 52 1 P 65M1 Measles/mumps/rubella vaccn.
14/07/97 54 2 c 64F4 18 month exam. Normal
30/03/99 56 2 P 64H4 3.5 year exam. Normal
30/03/99 58 2 P 64N7 Child exam.: testes
01/04/99 60 6 C 22G2 O/E – parotid swelling
05/05/99 62 7 C H161 Acute bronchitis
05/05/99 63 7 M 100 s3 A e3zk AMOXYCILLIN 125 mg/5 mL s/f susp
09/08/99 64 8 C L15. Impetigo
09/08/99 65 8 M 100 s4 A e22j FLUCLOXACILLIN 125 mg/5 mL syrup
15/10/99 66 9 C F631 Acute suppurative otitis media
15/10/99 67 9 M 100 s3 A e31k AUGMENTIN 125/31 in 5 mL susp
05/01/00 68 1 P 65K4 Booster DT(double)+polio vacc.
05/01/00 70 1 P 65MA MMR booster
02/08/00 72 1 P 657E First meningitis C vaccination
02/08/00 74 1 P 657I Single meningitis C vaccinatn
Key; Event Day of Event. Seq Sequence Number. This is a unique sequential identifier for each entry in the "Notes". It also provides the link 
between "Notes" and "Issues". Probno Problem Number. This identifies all entries linked together under the problem-orientated linkage. Type 
Note Type. Defines the entry (C = Current/Major Problem Heading, M = Medication, P = Prevention, A = Administration and so on) Dosea 
Dosage Amount. Refers to drugs entries in the "Issues" only. Dosei Dosage Instructions. Refers to drugs entries in the "Issues" only. Repeat 
Repeat / Acute Flag. Refers to drugs entries in the "Issues" only. ReadRC 4 Byte Read Code. ReadRu Rubric for Read Code.
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would be fair by having a fixed follow-up period; (iii) the
data sets were of manageable size.
Comparisons of the volume of recording of diagnoses and 
prescribing in GPRD and DIN
To further investigate the extent to which DIN relies on
linkage, the average number of prescriptions versus the
average number of diagnoses (and symptoms) in the first
5 years of life was compared between practices within
databases, and between databases. Read and OXMIS
Codes for entries referring to administration, family his-
tory of disease, procedures and examinations were
excluded. We made the pragmatic decision to refine the
analysis by measuring diagnosis days and prescription days
– that is number of days on which a diagnosis was
recorded or a drug was prescribed. In DIN, a day on which
a prescription was made was then defined as being linked
to a diagnosis if the problem number it was associated with
had appeared previously in the child's record with a diag-
nosis (or symptom).
Identifying DIN practices using linkage satisfactorily and 
assessing its appropriateness
In DIN, the percentage of prescriptions that link to a prob-
lem number is high (>80% at least for all practices, >90%
for most) because it was one of the data quality indicators
used to select practices, and data from within practices.
However, this indicator of linkage does not guarantee a
properly structured problem orientated medical record.
For example, a practice could link all its prescriptions to a
single problem number. Such a practice might be keeping
excellent records, and the data would be useful for many
purposes, but linkage of problem headings would be
meaningless.
Three criteria based on diagnoses found in the problem
headings were used to identify practices which were not
using linkage in a way useful for research: (i) reliance on
non-specific Read Codes for problem headings (11 prac-
tices had >20% 'level 1' Read codes); (ii) reliance on prac-
tice-specific Read Codes for problem headings for which
we have no rubric (7 practices had >20% such codes) and;
(ii) opening too few problem headings per person on
average (2 further practices were clear outliers in this
regard). This left 121 practices that we believed would be
suitable for an analysis based on linkage to problem
headings.
To assess the reliability and potential usefulness of linkage
in DIN, the analysis focused on emollients (BNF chapter
13.2.1). Emollients were chosen as they are predomi-
nantly prescribed for a single condition (eczema), fre-
quently diagnosed and prescribed for in general practice.
Eczema was defined by the following Read Codes – L2..
(dermatitis/eczemas), L22. and all sub-codes (Sebor-
rhoeic dermatitis/eczema), L23. and all sub-codes (Atopic
eczema/dermatitis), L24. and all sub-codes (Contact der-
matitis/eczema), L25. and all subcodes (ingestion derma-
titis), F5C4 (dermatitis of eyelid) and 2F13 (dry skin). We
assessed emollient to eczema linkage in three ways in DIN
– same day, linked by problem number anywhere in the
record, and linked to a problem heading only.
Computing
Data handling at St George's was carried out using SAS
version 8.1 (SAS Institute Inc., North Carolina, USA) run-
ning under UNIX on a Sun Microsystem dual processor
with large scale rapid access storage using RAID
technology.
Statistical methods
The paper is essentially descriptive, comparing the level of
recording of various items within two large databases of
tens of thousands of patients. Means, medians and inter-
quartile ranges are used to characterise the distributions,
many of which are skewed. Despite this skewness, means
are well estimated based on large numbers of observa-
tions, and have the merit of relating directly to the total
level of recording/prescribing. For this reason means were
also used for studying variation in record lengths between
practices. PROC MIXED in SAS was used to estimate the
within practice and between practice components of vari-
ance within each database (with practice fitted as a ran-
dom effect). The average percentage of variation between
practices which was attributable to chance (sampling var-
iation) was then calculated. Plots of the mean level of the
number of days with diagnostic codes against the number
of days on which prescriptions were issued were restricted
to practices contributing more than 25 children to limit
the role of sampling variation.
Results
111,621 children were deemed to be "born into" DIN,
and 504,273 "born into" GPRD. We study here only those
with 5 years continuous follow-up: 40,183 in DIN and
76,310 in GPRD.
Comparison of the birth cohorts
The main differences between the birth cohorts are high-
lighted in Table 2. Since the DIN database builds up from
the early 90's, peaking in 1998 before practices started to
switch to the newer System 6000 – the birth year with the
most births who were followed for 5 years in DIN was
1994. (As we only consider DIN data recorded to February
2002 here, there are very few 1997 births). By contrast,
GPRD data available to us only existed to 1998, so there
are no births after 1993. The smaller range of birth years
in GPRD also resulted in fewer children per practice (less
than 100 in 69% of practices compared with in 37% of
practices in DIN). There were no important differences in
BMC Family Practice 2003, 4 http://www.biomedcentral.com/1471-2296/4/14
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the record length indicators between the DIN children
born in 1989–93 (where we have GPRD data) and those
in 1994–97 (Table 3). All subsequent analyses are thus
based on the combined DIN dataset over all years.
The mean number of days per patient on which a drug was
prescribed was similar between databases (19.5 in DIN vs.
19.8 in GPRD, Table 2), but mean days with a diagnostic
code were lower in DIN (15.8 vs. 22.9 in GPRD). Includ-
ing prescriptions that were linked to a diagnostic code
raised the DIN mean to 23.1 days. The mean number of
days per patient with either a drug prescribed or a diag-
nostic code recorded (or both) was slightly higher in
GPRD than in DIN (27.4 v 26.0 days).
While differences in mean record lengths between data-
bases were small after allowing for linkage, differences
between practices were marked within both databases
(Table 4). Thus the practice means for the average number
of days in which a prescription was issued in the first 5
years of life had an inter-quartile range of 16.4 to 22.3 in
DIN and 15.5 to 22.5 in GPRD (Table 4). Very little of the
practice variation is due to chance variation – that is sam-
pling variation arising from which individuals by chance
were in a given practice. The percentage due to sampling
variation is smaller in DIN due to the greater number of
children per practice. The percentage for number of days
with diagnostic codes is particularly small in DIN because
this figure is highly dependent on the way in which prac-
tices structure their records; the real differences between
practices are thus correspondingly greater.
The inter-practice relationship between prescribing and
recording of diagnostic codes is displayed in Figure 1, sep-
arately for each database. In order to limit the role of sam-
pling error, only practices with at least 25 children are
included in the plots. Generally high prescribing practices
are also those which use the most diagnostic codes, how-
ever the correlation was much weaker in DIN (r = 0.41,
Figure 1a) than in GPRD (r = 0.81 Figure 1c). Adjustment
for linkage in DIN produced a similar correlation (r =
0.85, Figure 1b) to that seen in GPRD.
Linkage of emollients to eczema in DIN
More children had a prescription for an emollient in DIN
(41.8%) than in GPRD (36.6%) during their first five
years of life (Table 5). Although these children were more
likely to have had an eczema diagnosis in DIN (91.7%)
than in GPRD (80.3%), the diagnosis was less likely to
appear on the same day as the emollient prescription in
DIN than in GPRD (19.4% v 32.7%). However, in DIN
86.4% of all emollient prescriptions appeared under a
problem heading which also included a diagnosis of
Table 2: Comparison of the DIN and GPRD birth cohorts
DIN (141 practices) GPRD (464 practices)
# children % # children %
Total with 5 years follow up 40,183 76,310
Sex
Boys 20,575 51.2% 38,904 51.0%
Girls 19,608 48.8% 37,406 49.0%
Birth Year
1989 511 1.3% 13,772 18.0%
1990 3,003 7.5% 18,946 24.8%
1991 4,421 11.0% 17,532 23.0%
1992 5,412 13.5% 14,646 19.2%
1993 6,802 16.9% 11,414 15.0%
1994 7,410 18.4% 0 0%
1995 6,730 16.8% 0 0%
1996 5,373 13.4% 0 0%
1997 521 1.3% 0 0%
# practices % # practices %
Number of children contributed to the birth cohort by practice
0–100 20 14.2% 172 37.1%
100–200 32 22.7% 146 31.5%
200–300 33 23.4% 80 17.2%
300–400 22 15.6% 38 8.2%
400–500 20 14.2% 18 3.9%
>500 14 9.9% 10 2.1%
BMC Family Practice 2003, 4 http://www.biomedcentral.com/1471-2296/4/14
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eczema (whether as the problem heading or simply as one
of several linked diagnoses) and 75.4% of all emollient
prescriptions appeared under a problem heading of
eczema.
However, there is marked variation between practices in
the percentage of emollient prescriptions that link to a
problem heading of eczema (Figure 2). It is apparent that
those 20 practices identified a-priori as not using problem
headings satisfactorily included all but two practices with
poor emollient to eczema linkage (Figure 2). These two
were readily explained by their reliance on Read codes
("2227" Rash Present and "L4ZZ" Skin disorders not oth-
erwise specified) that did not fit our definition of eczema,
but in all likelihood were used by the practices to repre-
sent it. After excluding these 20 practices, the percentage
of all emollient prescriptions appearing under a problem
heading of eczema rose to 83.5%.
An analysis of the problem headings under which emol-
lient prescriptions were issued was carried out for the 121
practices using problem headings satisfactorily. A total of
14,938 problem headings were used under which a pre-
scription for an emollient was issued. Of these problem
headings 76.9% (11,480/14,938) were defined as eczema;
4.7% (709) were other skin conditions (e.g. "L15."
Impetigo); 7.6% (1,135) were other skin symptoms (e.g.
"2227" Rash Present); and 4.6% (689) were non-specific
entries (which may well be eczema e.g. "L...;" Skin/subcu-
taneous tissue disease). Only 6.2% (925) of headings
appeared to be unsuitable reasons for an emollient
prescription.
Discussion
This report has illustrated some similarities and differ-
ences between two large-scale UK general practice compu-
ter databases. While both have similar levels of
prescribing, problem orientated linkage in DIN results in
Table 3: Comparison of record length in the DIN and GPRD birth cohorts
DIN GPRD
1989–93 births 
(n = 20,149)
1994–97 births 
(n = 20,034)
1989–1997 births (n = 40,183) 1989–93 births (n = 76,310)
Mean Mean Mean Median IQR Mean Median IQR
No. of days with a prescription issued 19.6 19.4 19.5 14 8–24 19.8 15 9–26
No. of days with diagnostic codes 15.8 15.7 15.8 13 8–21 22.9 20 13–30
No. of days with diagnostic codes or 
drugs linked to existing diagnostic codes
23.0 23.2 23.1 18 10–30 _ _ _
No. of days with either diagnostic or 
drugs or both codes
25.9 26.0 26.0 20 12–33 27.4 23 14–35
 – mean number of events in the first 5 years of life averaged across all individuals  – median number of events in the first 5 years of life across 
all individuals  – lower and upper quartiles of number of events in the first 5 years of life across all individuals
Table 4: Practice variation in average record lengths in the DIN and GPRD birth cohorts
DIN (n = 141) GPRD (n = 464)
Lower 
quartile Median
Upper 
quartile
% variation 
between 
practices due to 
sampling 
variation
Lower 
quartile Median
Upper 
quartile
% variation 
between 
practices due to 
sampling 
variation
No. of days with a prescription issued 16.4 18.5 22.3 5.2% 15.5 18.4 22.5 8.3%
No. of days with diagnostic codes 10.6 15.4 20.0 1.5% 18.5 21.9 25.6 8.5%
No. of days with diagnostic codes or 
drugs linked to existing diagnostic codes
18.8 22.9 27.3 4.8% _ _ _ _
No. of days with either diagnostic or 
drugs or both codes
21.1 25.6 30.8 4.8% 22.5 25.7 30.7 9.9%
 – the 25th, 50th and 75th percentiles of the practice mean number of events in the first 5 years of life  – see statistical methods
? ? ? ? ? ? ? ?
? ?
?
?
?
?
?
?
?
?
?
? ?
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Scatter plots of mean number of days with a prescription versus mean number of days with a diagnosis by practice in the DIN and GPRD birth cohorts (minimum 25 children pe  ractic )Figure 1
Scatter plots of mean number of days with a prescription versus mean number of days with a diagnosis by 
practice in the DIN and GPRD birth cohorts (minimum 25 children per practice) Top figure – (a) DIN: Mean 
number of days with a prescription issued vs. diagnostic code (without linkage, n = 140). Middle figure – (b) DIN: Mean number 
of days with a prescription issued vs. diagnostic or linked diagnostic code (n = 140). Bottom figure – (c) GPRD: Mean number 
of days with a prescription issued vs. diagnostic code (n = 437)
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diagnosis and symptom codes occurring less frequently
than they do in GPRD. However, this disparity is elimi-
nated by taking account of linkage in DIN.
Comparing the databases
We know from preliminary work that the age-sex structure
of DIN is comparable to GPRD for the years in which they
overlap, as well as to the population of England and Wales
itself. In this report, we studied the composition of the
medical records in more depth by creating birth cohorts in
each database. The methodology used to create these was
similar in each, with the main difference being in their
data collection periods. Thus DIN includes births from
later years (1989–1997) compared with GPRD (1989–
1993) where we only had data available to 1998. Children
born into DIN in these later years had records of
comparable length and composition to children born in
during 1989–93, suggesting no appreciable bias was
incurred by comparing the two databases outright in the
analyses.
While prescribing records in the DIN and GPRD birth
cohorts appeared very similar, the usage of diagnostic
codes was more parsimonious in DIN. This is not unex-
pected, as users of the Meditel system in DIN are strongly
encouraged to take a problem orientated approach to
structuring the medical record. These fundamental differ-
ences explain why preliminary work we have carried out
suggest that period prevalence rates of disease based on
diagnostic codes alone are lower in DIN, while rates based
on treated disease (requiring associated medication plus
the existence of the diagnosis ever) are comparable.
In this study we attempted to account for the linkage in
DIN by assuming that a diagnosis was 'present' when a
prescription was made that linked into an existing diagno-
sis (i.e. it had the same problem heading number). This
adjustment resulted in DIN producing a very similar
number of 'diagnostic' days to that seen in GPRD (23.1 to
22.9).
Importantly such a definition is an indication of an ongo-
ing medical problem, not necessarily of a consultation, as
repeat prescriptions will also count as 'diagnostic' day
where they link to a diagnosis. It is difficult to produce a
similar definition within GPRD. However, the mean
number of days on which either a prescription was issued
or a diagnostic code was recorded is similar in the two
databases (26 in DIN, 27.4 in GPRD).
Quality of linkage
To validate further the quality of linkage in DIN, we stud-
ied a specific example in order to highlight some of the
potential problems. We chose a class of drugs (emol-
lients) that is commonly prescribed in children, and is
quite specific for the condition (eczema or dry skin) it is
prescribed for.
While the majority of emollient prescriptions were linked
to an eczema diagnosis this linkage was not specific. In
some practices many diverse diagnoses were listed under
a single problem heading. Our solution was to focus on
the problem headings themselves, and to lay down more
stringent requirements for what we considered 'good link-
age' and a better problem oriented medical record. We
Table 5: Summary of emollient prescribing and eczema recording in DIN and GPRD birth cohorts in the first 5 years of life
DIN GPRD
Number % Number %
Children
Total number of children 40,183 76,310
Of which have at least one emollient prescription 16,799 41.8% 27,955 36.6%
Children with an emollient prescription
Of which also have an eczema diagnosis recorded in first 5 years of life 15,404 91.7% 22,444 80.3%
Of which also have an eczema diagnosis recorded that can be linked by problem 
number (and thus under the same chapter heading) in first 5 years of life (DIN 
only)
14,583 86.8% _
Emollient prescriptions days
Total number of days with emollient prescriptions in first 5 years of life 85,870 123,413
Of which have an eczema diagnosis that appears on the same day 16,624 19.4% 41,647 32.7%
Of which an eczema diagnosis is made on the same day or can be linked to a 
previous one by problem number
74,217 86.4% _
Of which have a chapter heading of eczema 64,461 75.1% _
Of which have a chapter heading of eczema – excluding 20 practices (see 
methods n= 71,701)
59,688 83.3% _
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identified 20 practices that were using the system in ways
that would be unsuitable for any analysis based on link-
age. These practices were subsequently excluded in our
final analysis, though for many purposes their data would
be considered adequate.
Overall the linkage of emollient prescriptions to a satisfac-
tory diagnosis either within the record or based on prob-
lem heading was good. However, it varied markedly by
practice. Much of this variation was explained by the use
of less specific levels of the Read Code hierarchy by some
practices as the linkage was markedly improved by the
exclusion of the 20 'unsuitable' practices. Two remaining
practices, with notably sub-standard linkage of emollients
to eczema, were explained by their reliance on skin-
related Read Codes which did not fit our definition of
eczema.
Using Read Codes which appear as the problem heading
provides a single reason, and where that is a low level
code, a specific reason, for the prescription. Using all diag-
noses appearing under that problem heading is problem-
atic as multiple diagnoses and symptoms may appear
under the one problem heading. For emollients, we calcu-
lated that on average over five diagnostic codes were being
linked to each problem number. Many of these were valid
and represent the development of the condition (e.g. rash
becomes eczema), however some are unrelated. A likely
scenario is that when a child presents with two separate
problems on the same day, the GP does not always create
two separate problem entries.
Practice proportions of emollient prescriptions that link to an eczema chapter heading in 1st five years of lifeFigure 2
Practice proportions of emollient prescriptions that link to an eczema chapter heading in 1st five years of life 
Legend: Dark Shading – Not using chapter headings satisfactorily Light Shading – Using chapter headings satisfactorily
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The value of the Problem Orientated Medical Records for 
research
While the POMR was introduced as a way of improving
clinical care in a secondary care setting[2,8], it only
became feasible within primary care with the advent of
practice computer systems able to rapidly assemble data
for a patient into a number of different views[9]. The
debate over whether POMR should be an integral part of
the electronic patient record continues: one American
committee split over whether to recommend POMR[9]
while one UK group has argued for a more structured
record including timelines, problems, episodes and con-
sultations[10]. However, we are not aware of attempts to
evaluate the implications for research.
Our findings emphasise that in analysing data collected
using a system based on POMR it is crucial to take account
of linkage if sensible period prevalence rates are to be
obtained. A potential advantage of the Meditel system is
that the reason for prescribing a drug should be available:
this is of undoubted interest to drug companies, but also
in pharmaco-epidemiology. For example, an analysis of
why HRT was prescribed during the 1990's would be of
considerable interest. However, differences in the way
practices use problem headings – including inventing
their own or using rather broad headings such as "skin
problems" – raises important problems both for using
linkage for research purposes (where it requires valida-
tion) and with transferring records from one GP system to
another.
Whether or not POMR will be part of the electronic
patient record of the future, we have a decade's worth of
data collected using such a system during the 1990's. The
problem orientated linkage in the DIN database offers a
level of information about the relationship between diag-
noses and medication that does not exist in GPRD. It also
offers important advantages for understanding trends in
prescribing and for feedback to GPs compared to Prescrib-
ing Analysis and CosT (PACT) data, which lack links to
both demographic and clinical characteristics of those
prescribed for. In theory, the POMR structure should also
give insight into the evolution of diagnoses.
Conclusions
We have demonstrated the importance of comparing
large-scale GP databases based on fundamentally differ-
ent computing systems. While prescribing records in DIN
and GPRD appeared similar, the usage of diagnostic codes
is more parsimonious in DIN. However, if linkage of pre-
scriptions to problem headings is taken account of, then
the volume of diagnostic codes recorded in DIN is very
similar to that in GPRD and results in similar period prev-
alence rates for many conditions. A potentially important
advantage of the POMR structure of DIN, if used satisfac-
torily as it was in 121 of the 141 practices, is that most pre-
scriptions can be linked directly to a diagnostic heading,
providing a reason for the issue. This is but one example
of the value of carrying out research in parallel in data-
bases based on different systems. Others include the abil-
ity to validate findings found within one database and the
availability of different explanatory variables (with the
ability to adjust for them) such as a social indicator in
DIN[4] and a family index in GPRD[11].
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